Amniotic, Placental, and Umbilical Tissue Injections
What Patients Should Know About “Stem Cell” Claims
Many patients searching for “stem cell therapy” are surprised to learn that not all products marketed under this label are what they seem.
At Meier Orthopedic Sports Medicine, we believe patients deserve clear, honest, science-based information. While amniotic, placental, and umbilical tissue products are widely promoted in regenerative medicine, we do not use or recommend these products. Instead, we focus on advanced autologous orthobiologic therapies derived from your own body.
This page explains why.
What Are Amniotic, Placental, and Umbilical Tissue Products
Amniotic, placental, and umbilical tissues are derived from peripartum sources, meaning tissues associated with childbirth, including:
- Amniotic membrane
- Amniotic fluid
- Placental tissue
- Umbilical cord tissue
These products are processed, packaged, and sold commercially for injection into joints, tendons, and the spine.
They are often marketed as “stem cell therapy.”
Are These Products Actually Stem Cell Treatments?
This is one of the most important points for patients to understand.
Despite widespread marketing claims, most commercially available amniotic, placental, and umbilical products do NOT contain living stem cells at the time they are injected.
Why?
- These tissues are processed, preserved, and stored before use
- The processing methods required for storage eliminate cell viability
- Independent testing has repeatedly shown the absence of living stem cells in final products
In simple terms, you are not receiving live stem cells, even if the product is marketed that way.
Key Concerns With Peripartum Tissue Products
1. Lack of Living Cells
The core issue is misrepresentation. Patients are often told they are receiving stem cell therapy, when in reality, the injected product typically contains:
- Non-viable cellular material
- Structural proteins
- Variable concentrations of growth factors
This is fundamentally different from true biologic treatments using living cells.
2. Limited Regulation and Transparency
Unlike treatments derived from your own body, commercially distributed tissue products raise important concerns:
- Variability in processing methods
- Limited transparency about contents
- Inconsistent quality control between manufacturers
- Uncertainty regarding sterility and handling
This lack of standardization makes it difficult to know exactly what is being injected.
3. Safety Concerns
There have been reported cases of serious complications associated with these products, including infections.
Because these are donor-derived materials:
- They require strict handling and processing standards
- Any breakdown in sterility can pose a risk
- Patients have limited visibility into sourcing and preparation
Patient safety must always come first.
4. Heavy Commercial Influence
This is a rapidly growing, multi-million-dollar industry.
Some products are aggressively marketed to both physicians and patients, often:
- Using the term “stem cells” loosely or inaccurately
- Promoting benefits that are not supported by high-quality clinical evidence
- Minimizing discussion of limitations or risks
At Meier Orthopedic Sports Medicine, we believe in separating science from marketing.
Our Philosophy: Use Your Body’s Own Biology
Rather than relying on donor-derived products, we focus on autologous orthobiologic therapies, meaning treatments derived from your own body.
These include:
High-Dose Platelet-Rich Plasma (PRP)
- Concentrated platelets from your own blood
- Rich in growth factors that support healing
- Prepared with techniques that maximize biologic potency
Bone Marrow Aspirate Concentrate (BMAC)
- Contains living cells from your own bone marrow
- Includes progenitor cells and supportive biologic components
- Used in appropriate cases for advanced joint preservation
Plasma-Based Therapies (PPC)
- Concentrated anti-inflammatory and protective proteins
- Help improve the joint environment
A Comprehensive, Program-Based Approach to Regenerative Care
At Meier Orthopedic Sports Medicine, orthobiologic treatments are not used in isolation. Instead, they are part of structured, physician-directed programs designed to optimize outcomes based on each patient’s specific condition.
For patients with knee pain, cartilage injury, or arthritis, we offer our proprietary KneeJuvenation™ program; a comprehensive orthobiologic treatment strategy that may incorporate high-dose PRP, plasma-based therapies, and, when appropriate, bone marrow concentrate. The goal is not simply to reduce symptoms, but to improve the biologic environment of the joint and support long-term function.
For patients with spine-related pain, including disc and nerve-related conditions, our SpineJuvenation™ program integrates targeted orthobiologic injections with adjunctive therapies such as Class IV MLS laser and shockwave therapy. This combined approach is designed to reduce inflammation, support healing, and restore function; without relying on corticosteroids or repeated nerve ablation procedures.
This program-based model reflects a broader philosophy: the best outcomes are achieved through thoughtful combination and personalization of treatments – not one-size-fits-all injections.
Why Autologous Orthobiologics Make Sense
Using your own biology offers several important advantages:
- No risk of disease transmission
- Full transparency in what is being used
- Living, biologically active components
- Personalized treatment tailored to your condition
- Better alignment with natural healing processes
This approach reflects a core principle of modern regenerative medicine:
support the body’s ability to heal itself rather than introducing potentially harmful external products.
Do These Treatments Regrow Cartilage?
It is important to be honest and precise.
Orthobiologic treatments can:
- Reduce inflammation
- Improve joint function
- Decrease pain
- Support the biologic environment of the joint
However, injections alone do not regrow cartilage in a predictable or structural way.
When true cartilage restoration is needed, surgical techniques may be combined with biologics as part of a comprehensive joint preservation strategy.
A Smarter Approach to “Stem Cell Therapy”
If you are researching stem cell treatments, the most important questions to ask are:
- Are there living cells in the product?
- Where do they come from?
- How are they processed?
- What evidence supports their use?At our practice, we believe the most reliable and scientifically grounded answers come from your own biology.
The Bottom Line
Amniotic, placental, and umbilical tissue products are widely marketed, but they come with significant concerns:
- They are often mislabeled as “stem cell therapy”
- They typically do not contain living stem cells
- There is limited regulation and transparency
- Safety and consistency may vary
For these reasons, we do not use these products.Instead, we focus on advanced, physician-directed orthobiologic treatments using your own body’s natural healing capacity, combined with a comprehensive joint preservation strategy.
Learn More About Your Options
If you are exploring regenerative medicine treatments, we encourage you to learn about:
- High-dose PRP
- Bone marrow concentrate (BMAC) cell therapy
- Comprehensive joint preservation strategies
Our goal is to provide clear guidance, honest recommendations, and the most advanced biologic treatments available.
Frequently Asked Questions About Amniotic, Placental and Umbilical “Stem Cell” Injections
No. Most commercially available amniotic, placental, and umbilical tissue products do not contain living stem cells at the time of injection. While they may be marketed as “stem cell therapy,” independent testing has shown that the cells in these products are typically non-viable due to processing and storage methods.
The term “stem cell therapy” is often used loosely in marketing. It can refer to the original source of the tissue rather than what is actually present in the final product. This can be misleading for patients trying to understand what they are receiving.
There are potential safety concerns. Because these are donor-derived products, their safety depends heavily on how they are sourced, processed, and handled. There have been reported cases of infection and complications associated with these injections. Transparency and consistency can vary between manufacturers.
Some patients may experience symptom relief, likely due to growth factors or anti-inflammatory components. However, results are inconsistent, and these products are not equivalent to treatments using your own living cells. The scientific evidence supporting their effectiveness remains limited and variable.
PRP (platelet-rich plasma) is derived from your own blood and contains a high concentration of your body’s natural growth factors. It is fully autologous, meaning there is no risk of disease transmission and complete transparency in what is being used. In contrast, amniotic products are donor-derived and lack living cells.
Bone marrow concentrate is obtained from your own body and contains living cells, including progenitor cells, along with supportive biologic components. This makes it fundamentally different from processed amniotic products, which typically do not contain viable cells.
They may contain structural proteins, signaling molecules, and growth factors. However, the exact composition can vary depending on the manufacturer and processing methods, which are not always fully transparent.
We prioritize treatments that are scientifically grounded, transparent, and derived from your own body. Autologous orthobiologics such as high-dose PRP and bone marrow concentrate provide living biologic components and eliminate many of the concerns associated with donor-derived products.
The best approach depends on your condition, but in many cases, autologous orthobiologic treatments such as high-dose PRP or bone marrow concentrate offer a more reliable and biologically sound option. These treatments are often delivered as part of comprehensive care programs—such as our KneeJuvenation™ program for knee conditions or SpineJuvenation™ program for spine-related pain—designed to optimize results through a personalized treatment strategy.
In many cases, yes. Orthobiologic treatments can reduce pain, improve function, and delay or even avoid the need for surgery. When surgery is necessary, these treatments may also be used to support healing as part of a comprehensive joint preservation strategy.
Not All Regenerative Treatments Are the Same
If you are considering “stem cell therapy,” it is important to understand exactly what is being offered—and whether it aligns with current science.
At Meier Orthopedic Sports Medicine, we focus on advanced, autologous orthobiologic treatments delivered through structured programs such as KneeJuvenation™ and SpineJuvenation™, designed to support healing, improve function, and help patients avoid unnecessary surgery whenever possible. The first step is an expert evaluation.
We take the time to understand your condition, explain your options clearly, and develop a personalized treatment strategy tailored to your specific condition and goals.
